Loading…
The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease
Parkinson's disease (PD) is an aging-associated neurodegenerative disorder with the hallmark of abnormal aggregates of alpha-synuclein (α-syn) in Lewy bodies (LBs) and Lewy neurites (LNs). Currently, pathogenic α-syn and mitochondrial dysfunction have been considered as prominent roles that giv...
Saved in:
Published in: | Biophysical chemistry 2023-12, Vol.303, p.107122-107122, Article 107122 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Parkinson's disease (PD) is an aging-associated neurodegenerative disorder with the hallmark of abnormal aggregates of alpha-synuclein (α-syn) in Lewy bodies (LBs) and Lewy neurites (LNs). Currently, pathogenic α-syn and mitochondrial dysfunction have been considered as prominent roles that give impetus to the PD onset. This review describes the α-syn pathology and mitochondrial alterations in PD, and focuses on how α-syn interacts with multiple aspects of mitochondrial homeostasis in the pathogenesis of PD.
[Display omitted]
•The relationship between α-syn pathology and mitochondrial dysfunction is reciprocal in PD.•α-syn affects mitochondrial biogenesis, bioenergetics, dynamics, transport and quality control.•Mitochondrial dysfunction in turn leads to the α-syn pathology.•More researches are needed to investigate the interaction between α-syn pathology and mitochondrial dysfunction. |
---|---|
ISSN: | 0301-4622 1873-4200 |
DOI: | 10.1016/j.bpc.2023.107122 |